Sidewinder Therapeutics
Biotechnology company focused on development of precision large-molecule therapeutics, with an emphasis on antibody-drug conjugate (ADC) approaches for oncology and rare diseases. The organization states expertise in drug discovery and development and advances programs targeting specific molecular drivers of disease.
Industries
N/A
Expertise Areas
- Precision ADC therapeutics
- Large-molecule biologics discovery
- Oncology and rare disease therapeutics
- Translational drug development
Key Technologies
- Antibody-drug conjugates (ADCs)
- Large-molecule biologics
- Targeted molecular therapeutics